“Neuroendocrine tumors, the kind that Apple Chief Executive Officer Steve Jobs had surgically removed during the weekend, fall into a tiny category of pancreatic cancers that tend to grow very slowly and have a high survival rate, medical experts said Monday,” Ulysses Torassa reports for The San Francisco Chronicle. “Jobs’ form of the disease accounts for less than 5 percent of the 32,000 pancreatic cancer cases diagnosed each year in the United States.”

“Dr. Jeffrey Norton, a specialist in cancers of the digestive system at Stanford University Medical Center, said an estimated 80 to 90 percent of patients are still alive after 10 years, although predictions are difficult because the number of cases is so small,” Torassa reports.

Full article here.

MacDailyNews Take: Leave it to Steve to get the rare form (less than 5%) of pancreatic cancer that closely matches Mac market share. Thank God!